U.S. market Closed. Opens in 6 hours 7 minutes

AUTL | Autolus Therapeutics plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-30
Revenue1.70M6.19M2.33M242.00K2.91M1.05M1.69M1.21M
Cost of Revenue6.57M137.22M128.65M134.89M4.61M48.30MN/AN/A
Gross Profit-4.87M-131.03M-126.32M-134.65M-1.70M-47.25MN/AN/A
Operating Expenses190.16M173.72M166.65M168.39M144.87M41.48M25.11M15.59M
Selling, General & Admin40.18M31.90M31.86M34.97M39.45M16.85M9.10M5.15M
Research & Development130.48M141.99M134.79M134.89M105.42M24.64M16.01M10.44M
Other Operating Expenses-19.50M-166.00K-145.00K-1.47M4.51M3.97MN/AN/A
Operating Income-195.03M-163.78M-164.21M-168.15M-137.86M-57.53M-23.42M-14.38M
Other Expenses / Income-13.37M-9.42M-1.78M1.89M-1.15M3.97M38.00K49.00K
Before Tax Income-208.40M-173.21M-165.99M-166.26M-139.01M-36.33M-23.38M-14.33M
Income Tax Expenses-19.00K-24.37M-23.89M-24.16M-15.16M-5.21M-3.65M-1.78M
Net Income-208.38M-148.84M-142.10M-142.09M-123.85M-31.11M-19.73M-12.55M
Interest Expenses45.07M8.90M1.10MN/AN/A12.67KN/AN/A
Basic Shares Outstanding173.94M94.99M72.08M51.56M43.07M31.56M43.90M13.78M
Diluted Shares Outstanding173.94M94.99M72.08M51.56M43.07M31.56M43.90M13.78M
EBITDA-188.46M-156.36M-155.75M-162.49M-133.25M-35.21M-22.37M-13.85M
EBITDA Margin-11,099.12%-2,524.43%-6,684.51%-67,143.39%-4,582.15%-3,368.18%-1,321.38%-1,142.66%
EBIT-163.34M-164.30M-164.88M-166.26M-139.01M-36.31M-23.38M-14.33M
EBIT Margin-9,619.26%-2,652.57%-7,076.52%-68,701.24%-4,780.19%-3,473.88%-1,380.98%-1,182.10%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙